Cohort Profile: The Haematological Malignancy Research Network (HMRN); a UK population-based patient cohort

Alexandra Smith; Debra Howell; Simon Crouch; Dan Painter; John Blase; Han-I Wang; Ann Hewison; Timothy Bagguley; Simon Appleton; Sally Kinsey; Cathy Burton; Russell Patmore; Eve Roman

doi:10.1093/ije/dyy044

Cohort Profile: The Haematological Malignancy Research Network (HMRN); a UK population-based patient cohort

Alexandra Smith, Debra Howell, Simon Crouch, Dan Painter, John Blase, Han-I Wang, Ann Hewison, Timothy Bagguley, Simon Appleton, Sally Kinsey, Cathy Burton, Russell Patmore, Eve Roman

Health Sciences

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	700-700g
Number of pages	8
Journal	International Journal of Epidemiology
Volume	47
Issue number	3
Early online date	2 Apr 2018
DOIs	https://doi.org/10.1093/ije/dyy044
Publication status	Published - Jun 2018

Bibliographical note

© The Author(s) 2018

Funding Information:
specifically established in the UK in 2004 to address the needs outlined above by producing ‘real-time’, robust generalizable data on haematological malignancies to inform contemporary clinical practice and research: locally, nationally and internationally.28 With core support from Bloodwise [www.bloodwise.org.uk], formerly Leukaemia and Lymphoma Research, HMRN is the result of a unique collaboration between university researchers, National Health Service (NHS) clinicians and patients/carers.

Funding Information:
This work was supported by Bloodwise [grant number 15037], and has ethics approval (REC 04/01/1205/69) from Leeds West Research Ethics Committee, R&D approval from each NHS Trust and exemption from Section 251 of the Health & Social Care Act (PIAG 1–05(h)/2007).

Access to Document

10.1093/ije/dyy044

Cohort Profile The Haematological Malignancy
© The Author(s) 2018
Final published version, 603 KB

https://academic.oup.com/ije/advance-article/doi/10.1093/ije/dyy044/4958802?guestAccessKey=01671eae-7536-4a1e-b735-5142f2a0513e

Cite this

@article{2ba04d4e3e7e4e978becf65a68f02d7e,

title = "Cohort Profile: The Haematological Malignancy Research Network (HMRN); a UK population-based patient cohort",

author = "Alexandra Smith and Debra Howell and Simon Crouch and Dan Painter and John Blase and Han-I Wang and Ann Hewison and Timothy Bagguley and Simon Appleton and Sally Kinsey and Cathy Burton and Russell Patmore and Eve Roman",

note = "{\textcopyright} The Author(s) 2018 Funding Information: specifically established in the UK in 2004 to address the needs outlined above by producing {\textquoteleft}real-time{\textquoteright}, robust generalizable data on haematological malignancies to inform contemporary clinical practice and research: locally, nationally and internationally.28 With core support from Bloodwise [www.bloodwise.org.uk], formerly Leukaemia and Lymphoma Research, HMRN is the result of a unique collaboration between university researchers, National Health Service (NHS) clinicians and patients/carers. Funding Information: This work was supported by Bloodwise [grant number 15037], and has ethics approval (REC 04/01/1205/69) from Leeds West Research Ethics Committee, R&D approval from each NHS Trust and exemption from Section 251 of the Health & Social Care Act (PIAG 1–05(h)/2007).",

year = "2018",

month = jun,

doi = "10.1093/ije/dyy044",

language = "English",

volume = "47",

pages = "700--700g",

journal = "International Journal of Epidemiology",

issn = "0300-5771",

publisher = "Oxford University Press",

number = "3",

}

TY - JOUR

T1 - Cohort Profile

T2 - The Haematological Malignancy Research Network (HMRN); a UK population-based patient cohort

AU - Smith, Alexandra

AU - Howell, Debra

AU - Crouch, Simon

AU - Painter, Dan

AU - Blase, John

AU - Wang, Han-I

AU - Hewison, Ann

AU - Bagguley, Timothy

AU - Appleton, Simon

AU - Kinsey, Sally

AU - Burton, Cathy

AU - Patmore, Russell

AU - Roman, Eve

N1 - © The Author(s) 2018 Funding Information: specifically established in the UK in 2004 to address the needs outlined above by producing ‘real-time’, robust generalizable data on haematological malignancies to inform contemporary clinical practice and research: locally, nationally and internationally.28 With core support from Bloodwise [www.bloodwise.org.uk], formerly Leukaemia and Lymphoma Research, HMRN is the result of a unique collaboration between university researchers, National Health Service (NHS) clinicians and patients/carers. Funding Information: This work was supported by Bloodwise [grant number 15037], and has ethics approval (REC 04/01/1205/69) from Leeds West Research Ethics Committee, R&D approval from each NHS Trust and exemption from Section 251 of the Health & Social Care Act (PIAG 1–05(h)/2007).

PY - 2018/6

Y1 - 2018/6

UR - http://www.scopus.com/inward/record.url?scp=85054875615&partnerID=8YFLogxK

U2 - 10.1093/ije/dyy044

DO - 10.1093/ije/dyy044

M3 - Article

C2 - 29618056

SN - 0300-5771

VL - 47

SP - 700-700g

JO - International Journal of Epidemiology

JF - International Journal of Epidemiology

IS - 3

ER -

Cohort Profile: The Haematological Malignancy Research Network (HMRN); a UK population-based patient cohort

Bibliographical note

Access to Document

Other files and links

Cite this